Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

INTRODUCTION: Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tung, Nadine, Wang, Yihong, Collins, Laura C, Kaplan, Jennifer, Li, Hailun, Gelman, Rebecca, Comander, Amy H, Gallagher, Bridget, Fetten, Katharina, Krag, Karen, Stoeckert, Kathryn A, Legare, Robert D, Sgroi, Dennis, Ryan, Paula D, Garber, Judy E, Schnitt, Stuart J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Research article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://ncbi.nlm.nih.gov/pubmed/20149218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2478
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia